oxidopamine has been researched along with Alloxan Diabetes in 15 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
| Excerpt | Relevance | Reference |
|---|---|---|
| "During the early phase of scar formation/healing, the density of GAP43/nestin(+) fibres innervating the peri-infarct/infarct region was significantly increased, whereas neurofilament-M/nestin(+) fibres were absent." | 1.39 | The neurogenic response of cardiac resident nestin(+) cells was associated with GAP43 upregulation and abrogated in a setting of type I diabetes. ( Calderone, A; Chabot, A; Duquette, N; Hertig, V; Meus, MA, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (26.67) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, S | 1 |
| Taliyan, R | 1 |
| Chabot, A | 1 |
| Meus, MA | 1 |
| Hertig, V | 1 |
| Duquette, N | 1 |
| Calderone, A | 1 |
| Omiya, Y | 1 |
| Suzuki, Y | 1 |
| Yuzurihara, M | 1 |
| Murata, M | 1 |
| Aburada, M | 1 |
| Kase, Y | 1 |
| Takeda, S | 1 |
| Cohen, G | 1 |
| Heikkila, RE | 1 |
| Pelleymounter, MA | 1 |
| Lorden, JF | 1 |
| Mayer, JH | 1 |
| Clarke, SA | 1 |
| Wilson, HF | 1 |
| Tomlinson, DR | 3 |
| Ahlgren, SC | 1 |
| Levine, JD | 1 |
| Wallace, W | 1 |
| Ahlers, ST | 1 |
| Gotlib, J | 1 |
| Bragin, V | 1 |
| Sugar, J | 1 |
| Gluck, R | 1 |
| Shea, PA | 1 |
| Davis, KL | 1 |
| Haroutunian, V | 1 |
| Liu, J | 1 |
| Wang, KM | 1 |
| He, LZ | 1 |
| Cao, DY | 1 |
| Saitoh, A | 1 |
| Morita, K | 1 |
| Sodeyama, M | 1 |
| Kamei, J | 1 |
| Vo, PA | 2 |
| Kvist-Reimer, M | 1 |
| Sundler, F | 1 |
| Ahrén, B | 1 |
| Van der Zee, CE | 1 |
| Van den Buuse, M | 1 |
| Gispen, WH | 1 |
| Fedorak, RN | 1 |
| Chang, EB | 1 |
| Madara, JL | 1 |
| Field, M | 1 |
15 other studies available for oxidopamine and Alloxan Diabetes
| Article | Year |
|---|---|
High fat diet feeding induced insulin resistance exacerbates 6-OHDA mediated neurotoxicity and behavioral abnormalities in rats.
Topics: Animals; Corpus Striatum; Diabetes Mellitus, Experimental; Diet, High-Fat; Inflammation; Insulin Res | 2018 |
The neurogenic response of cardiac resident nestin(+) cells was associated with GAP43 upregulation and abrogated in a setting of type I diabetes.
Topics: Animals; Cicatrix; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Fibrosis; GAP-43 Prot | 2013 |
Antinociceptive effect of shakuyakukanzoto, a Kampo medicine, in diabetic mice.
Topics: Adrenergic alpha-Antagonists; Analgesics; Animals; Diabetes Mellitus, Experimental; Dose-Response Re | 2005 |
Alloxan and 6-hydroxydopamine: cellular toxins.
Topics: Alloxan; Animals; Blood Glucose; Brain; Diabetes Mellitus, Experimental; Free Radicals; Heart Atria; | 1984 |
Feeding, activity, and body temperature following 6-hydroxydopamine lesions in diabetes (db/db) mice.
Topics: Animals; Body Composition; Body Temperature; Body Weight; Brain; Catecholamines; Diabetes Mellitus, | 1983 |
The regrowth of right atrial noradrenergic nerves after 6-hydroxydopamine in genetically diabetic mice; effects of insulin treatment.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Heart; Heart Atria; Heart Rate; Hyd | 1982 |
Mechanical hyperalgesia in streptozotocin-diabetic rats is not sympathetically maintained.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Sympathetic; Hyperalgesia; | 1993 |
Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation.
Topics: 5,7-Dihydroxytryptamine; Acetylcholine; Actins; Afferent Pathways; Amyloid beta-Protein Precursor; A | 1993 |
[Effects of sympathetic efferent in diabetic hyperalgesia in rat].
Topics: Alprostadil; Animals; Diabetes Mellitus, Experimental; Dinoprostone; Efferent Pathways; Ganglia, Sym | 1996 |
Effects of the experimental diabetes on dopamine D1 receptor-mediated locomotor-enhancing activity in mice.
Topics: Animals; Benzazepines; Brain; Cocaine; Diabetes Mellitus, Experimental; Dopamine Agonists; Dopamine | 1998 |
The regeneration of peripheral noradrenergic nerves after chemical sympathectomy in diabetic rats: effects of nerve growth factor.
Topics: Animals; Atrial Function, Right; Diabetes Mellitus, Experimental; Electric Stimulation; Heart Atria; | 1999 |
Effects of nerve growth factor on expression of GAP-43 in right atria after sympathectomy in diabetic rats.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; GAP-43 Protein; Heart Atria; Immunoh | 2001 |
Effects of chemical sympathectomy by means of 6-hydroxydopamine on insulin secretion and islet morphology in alloxan-diabetic mice.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Female; Gene Expression; Insul | 2002 |
Beneficial effect of an ACTH-(4-9) analog on peripheral neuropathy and blood pressure response to tyramine in streptozocin diabetic rats.
Topics: Adrenocorticotropic Hormone; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Neur | 1990 |
Intestinal adaptation to diabetes. Altered Na-dependent nutrient absorption in streptozocin-treated chronically diabetic rats.
Topics: 3-O-Methylglucose; Alanine; Animals; Carrier Proteins; Diabetes Mellitus, Experimental; Hydroxydopam | 1987 |